Double Sidebars

July 8, 2021

Prof Kiat Ruxrungtham from the Center of Excellence in Vaccine Research Center and Development. Photo courtesy of Chulalongkorn Hospital

July 7, 2021

Kiat Ruxrungtham isn’t content to see Thailand wait in line to buy vaccines from another country.

July 6, 2021

The first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health

Posted in News | Tags: ,
July 2, 2021

Thailand is tightening border controls as the country faces its worst coronavirus outbreak.

July 2, 2021

Chulalongkorn University’s mRNA Covid-19 vaccine, ChulaCov19, began its first round of human trials

July 2, 2021

Thailand has begun human trials with two of four homegrown vaccine

Posted in News | Tags:
May 28, 2021

ChulaCov19 designer Kiat Ruxrungtham talks about his aim to make Thailand an mRNA vaccine hub

February 27, 2021

COWITH Talk – Season I EP.3 : COVID-19 Vaccine by Prof. Dr. Kiat Ruxrungtham

Posted in News | Tags:
November 27, 2020

A race to develop a vaccine against Covid-19 is paving the way for researchers in Thailand to produce inoculations against other diseases.

Posted in News | Tags: , ,
November 25, 2019

Organized by Chula Vaccine and Research Center (Chula VRC)

Posted in Events
September 19, 2019

Organized by Chula Vaccine and Research Center (Chula VRC)

Posted in Events
December 11, 2018

Organized by: Chula Vaccine Research Center (Chula VRC), Faculty of Medicine and Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
Venue: 12th Floor, Bhumisiri Building, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Free registration: 150 participants on the first come first serve basis
Deadline: November 30, 2018


Topics

  • Effect of SQ-21 and aluminum hydroxide gel on physical and adjuvant properties of Army Liposome Formulations (ALF)
  • Development of a cationic liposome-based adjuvant containing a TLR4 agonist
  • Immunogenicity and protective efficacy vaccine studies using Army Liposome Formulations (ALF) in NHP models
  • Assessment of the efficacy of nanoparticle-entrapped porcine reproductive and respiratory syndrome virus (PRRSV) vaccine
  • Polyvalent display on nanoparticles as the efficient delivery platform for eliciting immune responses of macromolecules
Posted in Events
March 20, 2018

To attend the Global Vaccine and Immunization Research Forum (GVIRF) 2018.

Posted in News
November 30, 2017

Organized: Chula Vaccine and Research Center (Chula VRC)
Sponsor: Thailand Centre of Excellent for Life Sciences (TCELS), National Vaccine Institute (Public Organization), National Science and Technology Development Agency (NSTDA), Chulalongkorn University
Venue: 12th Floor, Bhumisiri Building, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Free registration: 150 participants on the first come first serve basis
Deadline: 31 October 2017


Topics

30 November 2017

  • Nucleic Acid-based Vaccine; Synthetic vector-mediated IgG generated in vivo confers protective immunity against Emerging Viral Infection
  • Zika mRNA Vaccine
  • Dengue DNA Vaccine
  • HIV
  • mRNA-based vaccine
  • DNA Vaccine: from design to production

1 December 2017

  • Allergy Vaccine Overview
  • HDM Allergy DNA-based Vaccine
  • Pre-clinical development
  • In vivo expression of plasmid encoded IgG for immune check point targets by synthetic DNA: a new tool for cancer immunotherapy
Posted in Events
November 7, 2017

Seminar will start at 09.30 hrs., more information

Posted in Events
September 21, 2016

Sponsor: National Science and Technology Development Agency (NSTDA) and Thailand Centre of Excellent for Life Science (TCELS)
Venue: 12th Floor, Bhumisirimangkhlanusorn, Faculty of Medicine and Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
Free registration with limited number of participants: 100 for lecture, 20 for hand-on workshop
Deadline: 31 August 2016.
Registration by e-mail: Sunee Sirivichayakul (Sunee.s@chula.ac.th)


Topics

21 Sept 2016

  • Adjuvant Updates: past, present and how to choose the best adjuvant
  • TLR agonists as potential vaccine adjuvants
  • Liposome and related issues
  • Mucosal adjuvats
  • Emulsion-type (lipid based) adjuvants (MF59, AS03, Freund’s, microemulsion, nanoemulsion) and biopolymeric adjuvants
  • Adjuvants for Transcutaneous immunization
  • Mixed adjuvant formulations
  • Adjuvants for DNA vaccines

22 Sept 2016

  • Virus-like particle (VLP) Updates
  • Specific VLP for dengue
  • Bacteriophage-based VLP platform
  • VLP production from animal cells
  • Liposome-related workshop: brief overview
  • Liposome-related hand-on workshop

23 Sept 2016

  • VLP-related hand-on workshop
  • Meet the experts
Posted in Events
October 28, 2015

Organized by Chula Vaccine Research Center and NVI : Cordially invite you to attend